February 01, 2017

Protagonist Therapeutics to Participate in the Leerink Partners 6th Annual Global Healthcare Conference read more

January 17, 2017

Protagonist Therapeutics Initiates Phase 2b Study of Oral Drug Candidate PTG-100 in Ulcerative Colitis read more

January 05, 2017

Key Patent is Issued Covering Protagonist Therapeutics' Alpha4Beta7 Integrin Peptide Inhibitors including Oral Drug Candidate PTG-100 read more